Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel preparation method for Nebivolol intermediates offers high yield and chiral purity. Reliable supply chain partner for pharmaceutical manufacturing.
Patent CN107721858B reveals a novel asymmetric α-benzoylation method. Discover cost-effective chiral intermediate manufacturing with recyclable catalysts for global supply chains.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN101857887B enables high-purity aryl alcohol production. Reduced reaction time and cofactor costs ensure reliable supply chain performance.
Patent CN113717910B details a novel tri-enzyme system for (S)-citronellol synthesis, offering superior selectivity and scalable production for the global fragrance industry.
Novel two-step synthesis of axially chiral bissulfoxide ligands via oxidative coupling. High enantioselectivity for Rh-catalyzed additions. Reliable supply chain partner.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN101318146A reveals a novel organocatalyst enabling dual-handed synthesis of gamma-nitro ketones with high enantioselectivity, offering cost-effective solutions for API manufacturing.
Novel synthesis route for Tacalcitol side chain intermediates reduces cost and improves yield. Reliable supplier for high-purity pharmaceutical intermediates.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.
Novel asymmetric catalytic synthesis for chiral fluorinated building blocks. Enhances drug development efficiency and supply chain reliability for pharmaceutical intermediates.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Patent CN112430228B details a novel Rh-catalyzed route for chiral 2,3-dihydrobenzo[b]thiophene 1,1-dioxide, offering superior stereoselectivity and scalable manufacturing for API intermediates.
Novel synthesis route for esomeprazole intermediates via patent CN104098515B. Offers high yield, purity, and scalable production for global supply chains.
Patent CN102030690B details a novel two-step synthesis of axially chiral bissulfoxide ligands, offering high enantioselectivity and streamlined manufacturing for asymmetric catalysis applications.
Novel chiral synthesis route for Nebivolol HCl avoiding expensive raw materials. Ideal for reliable API intermediate suppliers seeking cost-effective scale-up.
Patent CN104513117B details copper-catalyzed asymmetric decarboxylation for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharma manufacturing.
Patent CN116354930A reveals a novel Pd/Cu catalyzed route for synthesizing chiral tetrahydroquinolines from amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.